Obesity/Cardiometabolic Clinical Development Director

amgen; United States; Hybrid; USD 250,000 - 340,000; Full time

Benefits offered by this job

Competitive benefits

Flexible work model

Career development

Job summary

Amgen, based in the United States, seeks a Clinical Development Director for Obesity/Cardiovascular to lead late‑phase studies within our AMG 133 program. You will collaborate across disciplines to design concepts, ensure regulatory alignment, and drive patient outcomes through scientific leadership.

The role requires an MD/DO with 3+ years in clinical research, strong communication, and leadership in a matrix environment, with a competitive compensation package and flexible work options.

Qualifications

• MD/DO from accredited medical school.

Responsibilities

• Provide clinical/scientific guidance on global evidence generation plans for obesity/cardiometabolic programs.

Skills

Communication skills

Leadership

GCP knowledge

Regulatory knowledge

Education

MD/DO degree

Tools

Electronic data review tools

Job description

Amgen, based in the United States, seeks a Clinical Development Director for Obesity/Cardiovascular to lead late‑phase studies within our AMG 133 program. You will collaborate across disciplines to design concepts, ensure regulatory alignment, and drive patient outcomes through scientific leadership.

The role requires an MD/DO with 3+ years in clinical research, strong communication, and leadership in a matrix environment, with a competitive compensation package and flexible work options.